Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Eikon Therapeutics, Inc. (EIKN) had Return on Investments of -18.95% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-88.41M |
|
-- |
|
-- |
|
$93.39M |
|
$-93.39M |
|
$4.99M |
|
$-88.41M |
|
$-88.41M |
|
$-88.41M |
|
$-88.41M |
|
$-88.41M |
|
$-88.41M |
|
$-93.39M |
|
$-88.34M |
|
54.14M |
|
54.14M |
|
$-1.63 |
|
$-1.63 |
|
| Balance Sheet Financials | |
$546.98M |
|
$133.07M |
|
$232.59M |
|
$779.57M |
|
$55.30M |
|
-- |
|
$257.77M |
|
$313.07M |
|
$466.50M |
|
$466.50M |
|
$466.50M |
|
54.15M |
|
| Cash Flow Statement Financials | |
$-154.76M |
|
$-156.79M |
|
$349.33M |
|
$113.07M |
|
$150.86M |
|
$37.79M |
|
$7.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-155.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.95% |
|
-18.95% |
|
-11.34% |
|
|
Return on Investments |
-18.95% |
$8.62 |
|
$-2.87 |
|
$-2.86 |
|